Search
 

Shorenstein Holding LOI for Mission Bay Site

SAN FRANCISCO-The locally headquartered fund sponsor is said to have a signed letter of intent with a drug maker for 53% of its 450,000 sf entitlement at Mission Bay.

By Brian K. Miller | Updated on August 07, 2006

SAN FRANCISCO-Shorenstein Properties LLC will be breaking ground at Mission Bay sooner rather than later, if the word on the street is any measure. The locally headquartered fund sponsor has a signed letter of intent from South San Francisco-based drug maker FibroGen for more than half of the 450,000 sf of development entitlement it acquired this time last year, local sources familiar with the situation tells GlobeSt.com.

Shorenstein has said its 3.8-acre Mission Bay development will consist of two five-story buildings each totaling plus-or-minus 225,000 sf. If the LOI with FibroGen is consummated, FibroGen would get a 240,000 sf building to itself plus expansion rights for what would end up being the 210,000-sf second building, according to one source. FibroGen is currently housed in about 100,000 sf at 225 Gateway Blvd. in South San Francisco. Both FibroGen and Shorenstein have declined comment.

According to multiple sources, Shorenstein executive vice president Tom Hart revealed at a local real estate discussion last week that the company was in advanced discussions with a tenant for the new development and was confident enough about breaking ground this fall that it had started purchasing construction materials including steel. FibroGen representatives were seen “hanging out” at the booth, according to one those sources.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.